Permanent link: https://www.iths.org/?p=28357
The ITHS KL2 Multidisciplinary Clinical Research Career Development Program provides the time, funding, mentorship, and training necessary to foster the early career development of clinical and translational researchers. The program is funded by the NIH and welcomes scholars from all health professions.
KL2 Scholars are appointed for up to three years of support. The program encourages all types of clinical research, including patient-oriented research, translational research, small- and large-scale clinical investigation and trials, epidemiologic and natural history studies, health services research, and health behavior research.
The KL2 program is a career development program for early-career investigators sponsored by the National Center for Advancing Translational Sciences (NCATS), a center of the National Institutes of Health (NIH).
The major components of the ITHS KL2 program are:
The KL2 program provides a minimum of 75% of a KL2 Scholar’s salary (up to $85,000 per year) for up to three years. In return, at least 75% of a KL2 Scholar’s full-time professional effort must be devoted to pursuing their KL2 research project, including the programmatic elements of the KL2 Program. Each KL2 Scholar’s home department, school, or institution will be required to provide institutional support for any KL2 Scholar whose salary support for their committed ITHS KL2 effort exceeds $85,000.
In addition to salary support, KL2 Scholars will receive research funds of up to $25,000/year based on an annual budget review and approval. KL2 Scholars will also receive up to $2,500//year to devote to travel to professional meetings and conferences.
The KL2 program is open to investigators at the postdoctoral or early career faculty level who plan to conduct, or are conducting, translational research.
Applicants are ineligible for the KL2 Program if they are:
An ITHS membership is required to apply. To become a member, please complete the ITHS Membership Form.
The KL2 Program application consists of standard demographic information, a biosketch from the NIH template, and a detailed and thorough description of your proposed project. In addition, you will need three letters of recommendation.
All materials, including the Letters of Recommendation, must be received by 11:59 p.m. on October 31, 2019.
You will need three letters of recommendation:
Applicants: Please direct people submitting letters for you to the Letter Submission Form as early as possible. All letters of recommendation are due on October 31, 2018.
1. Copy the following link, and deliver it any way you’d like (e.g. Craft your own email).
– OR –
2. Enter a few details into a form, and we’ll send the link to them for you.
Applicants will submit under one of the following three tracks of translational science that most accurately describes their proposed project.
|Therapeutic target identification and/or validation||Phase I or Phase II clinical studies/trials||Epidemiological studies such as case-control, cohort, or meta-analytic studies|
|Development of novel therapeutics prior to clinical testing||Biomarker identification & validation||Health disparities research|
|In vitro or cell-based assays||Pharmacokinetics / Pharmacodynamics of novel therapies in humans||Community-based & community participatory research|
|Research using animal models||Pilot & small proof-of-concept studies in humans||Implementation science|
Choose the translational science track in which your proposed project fits best (those unsure of which phase their research falls under should use the contact form to reach John Amory, KL2 Program Director, for guidance).
The NIH KL2 Mentored Clinical Research Scholars Program is funded through NCATS as part of a broad Clinical and Translational Science Awards (CTSA) Initiative.
We hope to select three KL2 scholars each year.
Yes. KL2 scholars are allowed to receive concurrent support from federal sources, as long as the effort dedicated to other grants does not reduce their KL2 effort to below 9 person-months and the support is for a different project with separate goals.
Specific information regarding individual CDAs
Individuals who have already obtained an individual Kaward will not be eligible to apply for our KL2 award.
The KL2 award is an Institutional Mentored Research CDA. It is similar in intent, scope, and funding to individual mentored K awards. All NIH Mentored CDAs have the same general level of effort requirements. However, there are several important differences. The application materials and time to notification are much shorter. A personal interview is required.
A core curriculum will be provided that will develop general scholarship in a breadth of clinical research topics. Intensive clinical research mentorship is also a primary focus of the CTSA KL2 award.
Finally, awards will be determined by a committee comprised of UW, Seattle Children’s, Fred Hutch, and other ITHS partner faculty and affiliated investigators.
Early career researchers are normally limited to 6 years of K-support overall. Since the ITHS KL2 program is designed for three years of support, applicants should not have received more than three years of K12 or KL2 support prior to applying. Furthermore, the applicant would need to justify additional mentored research training or training in a team context.
We have not established explicit limits on time since training. However, this award is best suited for applicants who are early in their professional careers. This award is not meant to serve as support for applicants already established in their field, nor is it meant to aid in a career change. Individuals who have achieved the rank of associate professor are not eligible.
KL2 scholars must hold a doctoral level degree. We are seeking individuals at an early stage of their career, even while they are in sub-specialty training. We expect that KL2 scholars will be postdoctoral level trainees or junior faculty who plan to conduct, or are conducting, clinical and translational research. Some KL2 scholars may be at the tenure-track/assistant professor level when they enter the program, but we hope most KL2 scholars will be at a much earlier stage. We expect that KL2 scholars will become assistant professor or tenure-track clinical research faculty either during or after they progress through the program.
KL2 scholars who achieve promotion to the rank of Associate Professor will have their appointments terminated at the end of the grant year in which this promotion is achieved.
Please see this link for more information:
KL2 funds cannot be used to support clinical fellowship training. However, fellows who have completed the part of their fellowship needed for sub specialty certification are eligible to apply. For example, although a Medical Oncology fellowship may last three to four years, fellows who have completed two years may be eligible to sit for the boards, and are therefore eligible. In general, applicants should be board-eligible for their specialty or subspecialty when they enter the KL2 program.
The KL2 program cannot support any investigators with a focus on global health and research located outside of the United States. While appointed to the KL2 program, scholars may not participate in any research work or travel outside of the United States and Canada (with the exception of international travel for conference attendance). Conducting research in the United States with foreign samples and data is allowed.
This program strongly encourages applications from members of all UW Health Science Schools. This includes the Schools of Pharmacy, Nursing, Public Health and Community Medicine, Social Work, Dentistry, and Medicine. In addition, the program strongly encourages applications from individuals at ITHS partner and collaborating institutions.
For information regarding this program, contact:
Manager of Training Programs
Institute of Translational Health Sciences
850 Republican Street, Box 358051, Seattle, WA 98109
Email / 206.543.0542 / fax 206.616.9250
Page last modified: Aug 28, 2019 @ 2:14 pm (PST)